It is a trading private limited company based in New Delhi, Delhi, India, established in 2016.
2016 | New Delhi, Delhi, India | Struck OffJan Kalyan Pharmaceuticals Private Limited, a struck off private limited company, was established on 18 January 2016 in New Delhi, Delhi, India. Engaging in retailers within the trade sector, it holds CIN: U51397DL2016PTC289665. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sangeeta Kapoor (Director), Rohit Mohan Kapoor (Director). Past directors included Raghuvinder Kumar, Ishita Grotra. Its latest AGM occurred on 10 August 2021, with the balance sheet filed on 31 March 2021. It is based at E-78, Ground Floor, Kalkaji, New Delhi, Delhi, 110019.
U51397DL2016PTC289665
289665
18 January 2016
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Jan Kalyan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangeeta Kapoor | Director | 20 Mar 2017 | Current |
| Rohit Mohan Kapoor | Director | 20 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Apr 2017 | Past |
| Pramod Abcsdd | Director | 14 Apr 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jan Kalyan Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Jan Kalyan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Jan Kalyan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jan Kalyan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jan Kalyan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Jan Kalyan Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Aug 2021 as per latest MCA records. was completed.
Progress on Jan Kalyan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was documented.
Sangeeta Kapoor was appointed as a Director was appointed as a Director on 20 Mar 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.
The activity Rohit Mohan Kapoor was appointed as a Director was appointed as a Director on 20 Mar 2017 & has been associated with this company since 8 years 8 months . was completed.
Progress on Jan Kalyan Pharmaceuticals Private Limited was registered on 18 Jan 2016 with Roc Delhi & aged 9 years 10 months as per MCA records. was documented.
The CIN of Jan Kalyan Pharmaceuticals Private Limited is U51397DL2016PTC289665.
Jan Kalyan Pharmaceuticals Private Limited is headquartered at E-78, Ground Floor, Kalkaji, New Delhi, Delhi, 110019.
Jan Kalyan Pharmaceuticals Private Limited was incorporated on 18 January 2016.
The current directors of Jan Kalyan Pharmaceuticals Private Limited are
The primary industry of Jan Kalyan Pharmaceuticals Private Limited is Trade.
Jan Kalyan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jan Kalyan Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Jan Kalyan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX